We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.31%
This Fund
S&P 500
This Quarter Est. Return
+42.64%
1 Year Est. Return
+106.31%
3 Year Est. Return
+266.76%
5 Year Est. Return
+310.53%
10 Year Est. Return
+1,580.35%
AUM
$1.46B
AUM Growth
+$256M
Cap. Flow
+$4.95B
Cap. Flow %
338.44%
Top 10 Hldgs %
14.04%
Holding
1,230
New
412
Increased
195
Reduced
230
Closed
293

Sector Composition

Rank Sector Weight
1 Technology 11.56%
2 Consumer Discretionary 8.68%
3 Healthcare 7.6%
4 Communication Services 6.73%
5 Industrials 4.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LFLYW
126
DELISTED
Leafly Holdings, Inc. Warrant
LFLYW
$2.82M 0.19%
288,373
JD icon
127
JD.com
JD
$44.6B
$2.82M 0.19%
46,864
+20,194
+76% +$1.02M
INFO
128
PUT
DELISTED
IHS Markit Ltd. Common Shares
INFO
$2.82M 0.19%
+373
New +$25.4K
CFFAW
129
DELISTED
CF Finance Acquisition Corp. Warrant
CFFAW
$2.81M 0.19%
258,708
-2,401
-0.9% -$1.81K
RVPHW
130
DELISTED
Reviva Pharmaceuticals Warrants
RVPHW
$2.8M 0.19%
260,086
AMZN icon
131
CALL
Amazon
AMZN
$2.92T
$2.76M 0.19%
200
NVDA icon
132
NVIDIA
NVDA
$4.86T
$2.75M 0.19%
289,000
-455,080
-61% -$3.68M
CLDX icon
133
Celldex Therapeutics
CLDX
$2.99B
$2.71M 0.19%
+208,836
New +$926K
CRWD icon
134
CrowdStrike
CRWD
$194B
$2.7M 0.18%
107,848
+77,848
+259% +$1.56M
ASND icon
135
CALL
Ascendis Pharma A/S
ASND
$16B
$2.69M 0.18%
+182
New +$25K
SBBX
136
DELISTED
SB One Bancorp Common Stock
SBBX
$2.68M 0.18%
136,191
+69,298
+104% +$1.2M
VINC
137
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$2.68M 0.18%
+13,000
New +$2.57M
LBTYA icon
138
Liberty Global Class A
LBTYA
$3.62B
$2.66M 0.18%
+121,812
New +$2.51M
AMAG
139
DELISTED
AMAG Pharmaceuticals
AMAG
$2.66M 0.18%
348,000
LSACW
140
DELISTED
LifeSci Acquisition Corp. Warrant
LSACW
$2.59M 0.18%
+260,000
New +$243K
THCAW
141
DELISTED
Tuscan Holdings Corp. II Warrant
THCAW
$2.58M 0.18%
256,400
RGT
142
Royce Global Value Trust
RGT
$98.8M
$2.53M 0.17%
218,959
+48,128
+28% +$494K
SPB icon
143
Spectrum Brands
SPB
$2.04B
$2.52M 0.17%
+55,000
New +$2.33M
QFIN icon
144
Qfin Holdings
QFIN
$1.69B
$2.52M 0.17%
+235,485
New +$2.14M
CIEN icon
145
Ciena
CIEN
$53.4B
$2.52M 0.17%
46,523
-35,809
-43% -$1.78M
ASMB icon
146
Assembly Biosciences
ASMB
$498M
$2.5M 0.17%
8,948
+83
+0.9% +$19.4K
REGN icon
147
Regeneron Pharmaceuticals
REGN
$78.5B
$2.5M 0.17%
4,000
-1,000
-20% -$568K
VOO icon
148
PUT
Vanguard S&P 500 ETF
VOO
$979B
$2.48M 0.17%
+316
New +$85.1K
NOK icon
149
Nokia
NOK
$51B
$2.44M 0.17%
555,077
+408,755
+279% +$1.54M
ACC
150
PUT
DELISTED
American Campus Communities, Inc.
ACC
$2.43M 0.17%
+694
New +$23K

Similar funds

Boothbay Fund Management's Q2 2020 Portfolio in Review

As of Q2 2020, Boothbay Fund Management held 1,230 positions worth $1.46B, up 21% from $1.21B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Boothbay Fund Management deployed $4.95B of net new capital in Q2 2020, opening 412 new positions and adding to 195 existing holdings. Its largest new stake was Tesla: 90,556,950 shares worth $25.6M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Sprott Physical Platinum and Palladium Trust, an estimated $11.4M trimmed.

  • Boothbay Fund Management's largest Q2 2020 buy was Tesla: 90,556,950 shares worth $25.6M.
  • Boothbay Fund Management added most to Alphabet (Google) Class C in Q2 2020, an estimated $27.1M increase.
  • Boothbay Fund Management's biggest Q2 2020 reduction was Sprott Physical Platinum and Palladium Trust, cutting an estimated $11.4M.
  • Boothbay Fund Management fully exited Allergan plc in Q2 2020, selling an estimated $46.4M.
  • Boothbay Fund Management's ten largest holdings make up 14% of its $1.46B portfolio in Q2 2020.
  • Boothbay Fund Management opened 412 new positions and closed 293 in Q2 2020.
  • Boothbay Fund Management's portfolio value rose 21% quarter-over-quarter to $1.46B.

Based on Boothbay Fund Management's 13F filing for Q2 2020, filed 14 Aug 2020.